Gel Documentation Systems Market Size

Global Gel Documentation Systems Market Overview

Gel Documentation Systems Market Size was valued at USD 0.35 Billion in 2023. The Global Gel Documentation Systems industry is projected to grow from USD 0.37 Billion in 2024 to USD 0.54 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.4% during the forecast period (2024 - 2032).

For the imaging and recording of nucleic acid and protein suspended inside polyacrylamide or agarose gels, hospitals, diagnostic laboratories, research institutes, pharmaceutical, and biotechnology corporations use gel documentation systems. Ethidium bromide or other fluorophores like SYBR Green are commonly used to stain these gels. These systems have various applications including protein quantification, monoclonal and polyclonal antibody binding affinities, gel and blot imaging, immunoassay, 2D electrophoresis, and nucleic acid quantification.

The global gel documentation system market is expected to expand in the next few years owing to several factors including the rising frequency of infectious diseases and genetic disorders, rising government funding for genomic and proteomic research, and ongoing technological improvements. Due to large clinical R&D spending by both government and commercial pharmaceutical and biotechnological businesses, and increased adoption of new technologies, the Americas are expected to lead the Gel Documentation Systems market.

Gel Documentation Systems Market Segment Insights

The Market has been segmented into Product, Detection techniques, Application and End user.

Gel Documentation Systems Product Insights

By product, the market has been segmented into instruments, accessories, and software. The instrument segment has been further segmented into digital gel documentation instruments and film gel documentation instruments. The instruments segment is estimated to hold major market share in the global gel documentation systems market due to the rising R&D activities in the biotechnology and pharmaceutical industries.

Gel Documentation Systems Technique Insights

On the basis of detection technique, the market has been segmented into ultraviolet, chemiluminescence, and fluorescence.On the basis of application, the market has been segmented into protein quantification, nucleic acid quantification, and others.

Gel Documentation Systems End-user Insights

The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic institutes & research centers, diagnostic laboratories, and others.The 

Gel Documentation Systems Regional Insights

Global Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The gel documentation systems market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Gel Documentation Systems Market has been segmented into Western Europe and Eastern Europe. The Western Europe Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Gel Documentation Systems Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the Gel Documentation Systems industry owing to the high clinical R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies, and rising adoption of advanced technologies. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion. Moreover, the increasing prevalence of genetic disorders in the region contributes to the market growth.

Europe is expected to hold the second largest position in the Gel Documentation Systems Market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The Gel Documentation Systems Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of proteomic and genomic studies in the region.

The Middle East & Africa has the lowest share of the  Gel Documentation Systems Market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Key players:

• Bio-Rad Laboratories, Inc.


• Bio-Techne


• Endress + Hauser Management AG


• GE Healthcare


• Thermo Fisher Scientific


• LI-COR Biosciences


• Vilber Lourmat


• Scientific Digital Imaging Plc.


• Cleaver Scientific


• Azure Biosystems

Gel Documentation Systems Market Segmentation 

Gel Documentation Systems Product Outlook

• Instruments
  
  
  
  • Digital Gel Documentation Instruments
  
  
  • Film Gel Documentation Instruments
  
  
  
  


• Software


• Accessories

Gel Documentation Systems Detection Technique Outlook

• Ultraviolet


• Chemiluminescence


• Fluorescence

Gel Documentation Systems Application Outlook

• Protein Quantification


• Nucleic Acid Quantification


• Others

Gel Documentation Systems End User Outlook

• Pharmaceutical & Biotechnology Companies


• Academic Institutes & Research Centers


• Diagnostic Laboratories


• Others

Gel Documentation Systems Region Outlook

• Americas
  
  
  
  • North America
    
    
    
    • US
    
    
    • Canada
    
    
    
    
  
  
  • South America
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• The Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Recent Development

A definitive business combination agreement has been reached between Gelesis, Inc., a biotherapeutics company developing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and Capstar Special Purpose Acquisition Corp., a special purpose acquisition company sponsored by Capstar Partners, LLC affiliates and certain private funds managed by PIMCO. Gelesis hopes to revolutionize weight management with the successful beta launch of its first product, Plenity, which is developed using a unique biomimetic medicinal platform.

Researchers at the Universidad Carlos III de Madrid (UC3M) have created a system that uses computer vision techniques to analyze biomedical movies acquired by microscopy in order to characterize and describe the behavior of the cells shown in the images. These novel methods have been applied to measuring live tissues. As a result, the researchers observed that neutrophils immune cells exhibit several behaviors in the blood during inflammatory processes, one of which is linked to the development of cardiovascular disease and is induced by the Fgr protein.Intended Audience:

• Gel Documentation System Manufacturers and Distributors


• Pharmaceutical and Biotechnological Companies


• Contract Research Organizations


• Academic and Research Institutes


• Government Associations